
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Hallmarks of neurodegenerative diseases
David M. Wilson, Mark Cookson, Ludo Van Den Bosch, et al.
Cell (2023) Vol. 186, Iss. 4, pp. 693-714
Open Access | Times Cited: 769
David M. Wilson, Mark Cookson, Ludo Van Den Bosch, et al.
Cell (2023) Vol. 186, Iss. 4, pp. 693-714
Open Access | Times Cited: 769
Showing 1-25 of 769 citing articles:
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Jian Sheng Loh, Wen Qi Mak, Li Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 202
Jian Sheng Loh, Wen Qi Mak, Li Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 202
Clinical applications of stem cell-derived exosomes
Fei Tan, Xuran Li, Zhao Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 201
Fei Tan, Xuran Li, Zhao Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 201
Alzheimer's disease: From immunotherapy to immunoprevention
Mathias Jucker, Lary C. Walker
Cell (2023) Vol. 186, Iss. 20, pp. 4260-4270
Open Access | Times Cited: 123
Mathias Jucker, Lary C. Walker
Cell (2023) Vol. 186, Iss. 20, pp. 4260-4270
Open Access | Times Cited: 123
Compilation of reported protein changes in the brain in Alzheimer’s disease
Manor Askenazi, Tomas Kavanagh, Geoffrey Pires, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 75
Manor Askenazi, Tomas Kavanagh, Geoffrey Pires, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 75
Accelerating Alzheimer’s therapeutic development: The past and future of clinical trials
Adam L. Boxer, Reisa A. Sperling
Cell (2023) Vol. 186, Iss. 22, pp. 4757-4772
Open Access | Times Cited: 71
Adam L. Boxer, Reisa A. Sperling
Cell (2023) Vol. 186, Iss. 22, pp. 4757-4772
Open Access | Times Cited: 71
Disease-specific tau filaments assemble via polymorphic intermediates
Sofia Lövestam, David Li, Jane L. Wagstaff, et al.
Nature (2023) Vol. 625, Iss. 7993, pp. 119-125
Open Access | Times Cited: 71
Sofia Lövestam, David Li, Jane L. Wagstaff, et al.
Nature (2023) Vol. 625, Iss. 7993, pp. 119-125
Open Access | Times Cited: 71
New strategies of neurodegenerative disease treatment with extracellular vesicles (EVs) derived from mesenchymal stem cells (MSCs)
Chella Perumal Palanisamy, Jinjin Pei, Phaniendra Alugoju, et al.
Theranostics (2023) Vol. 13, Iss. 12, pp. 4138-4165
Open Access | Times Cited: 66
Chella Perumal Palanisamy, Jinjin Pei, Phaniendra Alugoju, et al.
Theranostics (2023) Vol. 13, Iss. 12, pp. 4138-4165
Open Access | Times Cited: 66
Roles of Oxidative Stress in Synaptic Dysfunction and Neuronal Cell Death in Alzheimer’s Disease
Germán Plascencia‐Villa, George Perry
Antioxidants (2023) Vol. 12, Iss. 8, pp. 1628-1628
Open Access | Times Cited: 55
Germán Plascencia‐Villa, George Perry
Antioxidants (2023) Vol. 12, Iss. 8, pp. 1628-1628
Open Access | Times Cited: 55
Quinones as Neuroprotective Agents
Ángel Cores, Noelia Carmona-Zafra, José Clerigué, et al.
Antioxidants (2023) Vol. 12, Iss. 7, pp. 1464-1464
Open Access | Times Cited: 45
Ángel Cores, Noelia Carmona-Zafra, José Clerigué, et al.
Antioxidants (2023) Vol. 12, Iss. 7, pp. 1464-1464
Open Access | Times Cited: 45
Targeting synapse function and loss for treatment of neurodegenerative diseases
Borislav Dejanovic, Morgan Sheng, Jesse E. Hanson
Nature Reviews Drug Discovery (2023) Vol. 23, Iss. 1, pp. 23-42
Closed Access | Times Cited: 40
Borislav Dejanovic, Morgan Sheng, Jesse E. Hanson
Nature Reviews Drug Discovery (2023) Vol. 23, Iss. 1, pp. 23-42
Closed Access | Times Cited: 40
Investigating the Neuroprotective and Cognitive-Enhancing Effects of Bacopa monnieri: A Systematic Review Focused on Inflammation, Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis
Luiz José Valotto Neto, Matheus Reverete de Araujo, Renato Cesar Moretti, et al.
Antioxidants (2024) Vol. 13, Iss. 4, pp. 393-393
Open Access | Times Cited: 37
Luiz José Valotto Neto, Matheus Reverete de Araujo, Renato Cesar Moretti, et al.
Antioxidants (2024) Vol. 13, Iss. 4, pp. 393-393
Open Access | Times Cited: 37
Exploring the emerging trends in the synthesis and theranostic paradigms of cerium oxide nanoparticles (CeONPs): A comprehensive review
Sagnik Nag, Oishi Mitra, P. Sankarganesh, et al.
Materials Today Chemistry (2024) Vol. 35, pp. 101894-101894
Closed Access | Times Cited: 33
Sagnik Nag, Oishi Mitra, P. Sankarganesh, et al.
Materials Today Chemistry (2024) Vol. 35, pp. 101894-101894
Closed Access | Times Cited: 33
Spatial transcriptomics reveals molecular dysfunction associated with cortical Lewy pathology
Thomas Goralski, Lindsay Meyerdirk, Libby Breton, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 29
Thomas Goralski, Lindsay Meyerdirk, Libby Breton, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 29
The sense of antisense therapies in ALS
Sien Hilde Van Daele, Pegah Masrori, Philip Van Damme, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 3, pp. 252-262
Open Access | Times Cited: 24
Sien Hilde Van Daele, Pegah Masrori, Philip Van Damme, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 3, pp. 252-262
Open Access | Times Cited: 24
Mouse oocytes sequester aggregated proteins in degradative super-organelles
Gabriele Zaffagnini, Shiya Cheng, Marion Claudia Salzer, et al.
Cell (2024) Vol. 187, Iss. 5, pp. 1109-1126.e21
Open Access | Times Cited: 22
Gabriele Zaffagnini, Shiya Cheng, Marion Claudia Salzer, et al.
Cell (2024) Vol. 187, Iss. 5, pp. 1109-1126.e21
Open Access | Times Cited: 22
NRF2 Deficiency Promotes Ferroptosis of Astrocytes Mediated by Oxidative Stress in Alzheimer’s Disease
Zhi Tang, Zhuyi Chen, Min Guo, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 10, pp. 7517-7533
Open Access | Times Cited: 22
Zhi Tang, Zhuyi Chen, Min Guo, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 10, pp. 7517-7533
Open Access | Times Cited: 22
A synergetic turn in cognitive neuroscience of brain diseases
Agustín Ibáñez, Morten L. Kringelbach, Gustavo Deco
Trends in Cognitive Sciences (2024) Vol. 28, Iss. 4, pp. 319-338
Closed Access | Times Cited: 21
Agustín Ibáñez, Morten L. Kringelbach, Gustavo Deco
Trends in Cognitive Sciences (2024) Vol. 28, Iss. 4, pp. 319-338
Closed Access | Times Cited: 21
Heteromeric amyloid filaments of ANXA11 and TDP-43 in FTLD-TDP Type C
Diana Arseni, Takashi Nonaka, Max Jacobsen, et al.
Nature (2024) Vol. 634, Iss. 8034, pp. 662-668
Open Access | Times Cited: 20
Diana Arseni, Takashi Nonaka, Max Jacobsen, et al.
Nature (2024) Vol. 634, Iss. 8034, pp. 662-668
Open Access | Times Cited: 20
The six brain‐specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes
Sarah Buchholz, Hans Zempel
Alzheimer s & Dementia (2024) Vol. 20, Iss. 5, pp. 3606-3628
Open Access | Times Cited: 19
Sarah Buchholz, Hans Zempel
Alzheimer s & Dementia (2024) Vol. 20, Iss. 5, pp. 3606-3628
Open Access | Times Cited: 19
Innate immune activation in neurodegenerative diseases
Sergio Castro‐Gomez, Michael T. Heneka
Immunity (2024) Vol. 57, Iss. 4, pp. 790-814
Closed Access | Times Cited: 19
Sergio Castro‐Gomez, Michael T. Heneka
Immunity (2024) Vol. 57, Iss. 4, pp. 790-814
Closed Access | Times Cited: 19
Inflammatory aspects of Alzheimer’s disease
Pablo Botella Lucena, Michael T. Heneka
Acta Neuropathologica (2024) Vol. 148, Iss. 1
Closed Access | Times Cited: 19
Pablo Botella Lucena, Michael T. Heneka
Acta Neuropathologica (2024) Vol. 148, Iss. 1
Closed Access | Times Cited: 19
New perspectives on the therapeutic potential of quercetin in non-communicable diseases: Targeting Nrf2 to counteract oxidative stress and inflammation
Li Zhang, Li-Yue Xu, Fei Tang, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 14, Iss. 6, pp. 100930-100930
Open Access | Times Cited: 18
Li Zhang, Li-Yue Xu, Fei Tang, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 14, Iss. 6, pp. 100930-100930
Open Access | Times Cited: 18
Neuroprotective mechanisms of luteolin in glutamate-induced oxidative stress and autophagy-mediated neuronal cell death
Wudtipong Vongthip, Sunita Nilkhet, Kanokkan Boonruang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 18
Wudtipong Vongthip, Sunita Nilkhet, Kanokkan Boonruang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 18
Interplay of Proteostasis Capacity and Protein Aggregation: Implications for Cellular Function and Disease
Mark S. Hipp, F. Ulrich Hartl
Journal of Molecular Biology (2024) Vol. 436, Iss. 14, pp. 168615-168615
Open Access | Times Cited: 16
Mark S. Hipp, F. Ulrich Hartl
Journal of Molecular Biology (2024) Vol. 436, Iss. 14, pp. 168615-168615
Open Access | Times Cited: 16
Nanoparticle-Mediated Multiple Modulation of Bone Microenvironment To Tackle Osteoarthritis
Mengsi Zhan, Huxiao Sun, Zhiqiang Wang, et al.
ACS Nano (2024) Vol. 18, Iss. 15, pp. 10625-10641
Closed Access | Times Cited: 15
Mengsi Zhan, Huxiao Sun, Zhiqiang Wang, et al.
ACS Nano (2024) Vol. 18, Iss. 15, pp. 10625-10641
Closed Access | Times Cited: 15